Elon Musk is wrong, Bitcoin won t help us save the planet telegraph.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from telegraph.co.uk Daily Mail and Mail on Sunday newspapers.
Subscribe
Prosecutors in the trial against Derek Chauvin for three weeks argued that on May 25, 2020, when the white Minneapolis police officer knelt on the neck of George Floyd, a 46-year-old Black man, for more than nine minutes that it wasn t policing, it was murder.
After less than two days of deliberations, the 12-member jury agreed and found Chauvin guilty on the counts of second-degree unintentional murder, third-degree murder and second-degree manslaughter.
Subscribe
The landmark case, and trial, sparked protests against police brutality and galvanized support for racial justice in America. For UC Berkeley students, staff and faculty, the incident, which was videotaped for the world to see, was horrific. The verdict, though, brings some solace for the work ahead.
Laura Tyson April 21, 2021 08:36
With COVID-19 vaccines being rolled out and supportive fiscal and monetary policies fueling aggregate demand, the US economy is poised to return to its pre-pandemic output level later this year. The labor-market recovery, however, will be much slower and unevenly distributed, with employment unlikely to return to its pre-pandemic peak until 2024.
If output growth exceeds employment growth over the next few years, productivity will increase (at least temporarily). The Congressional Budget Office’s most recent forecast predicts labor-force productivity growth of 1.5% per year for the 2021-25 period, up from an average of 1.2% per year between 2008 and 2020.
In response to the pandemic, many firms – but especially large ones – have made significant strides toward boosting productivity through automation, digitalization, and the reorganization of operations, including a rapid shift to at-home work, to boost efficiency and resilience.
Share this article
Share this article
SOUTH SAN FRANCISCO, Calif., April 20, 2021 /PRNewswire/ Vera Therapeutics, Inc., a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced the appointment of Celia Lin, MD, as Chief Medical Officer. Dr. Lin brings extensive clinical and industry experience in orphan diseases and multiple therapeutic areas, including nephrology and inflammation. In addition, the Company announced the appointments of Tad Thomas, PhD, as Senior Vice President (SVP) and Head of Product Development and Manufacturing and Joseph Young, MBA, as SVP of Finance.
Vera Therapeutics Appoints Industry Veteran Dr. Celia Lin as Chief Medical Officer
Productivity after the pandemic jordantimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jordantimes.com Daily Mail and Mail on Sunday newspapers.